- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
© 2020 MJH Life Sciences and Endocrinology Network. All rights reserved.
Thyroid Disorders
Study Reports First Known Case of Subacute Thyroiditis After COVID-19 Infection
May 21, 2020
A new case study published in The Journal of Clinical Endocrinology & Metabolism, reports on an 18-year-old patient with COVID-19 infection and subacute thyroiditis.
L-Thyroxine Ineffective In Patients With Subclinical Hypothyroidism, Study Says
May 04, 2020
The common synthetic thyroid medication L-thyroxine has been shown to be ineffective in reducing symptoms in patients with subclinical hypothyroidism (SCH), according to a study published in the Annals of Internal Medicine.
VIDEO: Teprotumumab Offers Hope for Thyroid Eye Disease Patients
April 14, 2020
New research shows teprotumumab can be a beneficial treatment for patients suffering from thyroid eye disease (TED), even across age, gender and risk factor-based subgroups. In an interview with HCPLive®, Raymond Douglas, MD, PhD, director of the Orbital and Thyroid Eye Disease Center at the Cedars-Sinai Medical Center, explained the importance of the teprotumumab in treating this patient group and how the coronavirus disease 2019 (COVID-19) might impact thyroid eye disease patients.